Last updated on September 2018

A Study Comparing the Efficacy and Safety of TEV-48125 (Fremanezumab) for the Prevention of Chronic Cluster Headache (CCH)

Brief description of study

The purpose of the current study is to evaluate the efficacy and safety of TEV-48125 (Fremanezumab), in the prevention of CCH in adult patients.

Clinical Study Identifier: NCT02964338

Contact Investigators or Research Sites near you

Start Over

Teva U.S. Medical Information

Teva Investigational Site 40030
Helsinki, Finland